COVID-19: Biocon Biologics Raise Rs 225 crore, Board Approves 0.85% Minority Stake
On Friday, Biocon Ltd stated in a regulatory notice that Biocon Biologics India has approved a primary equity investment by Tata Capital Growth Fund. As per the consensus, Tata Capital…